Umut Kocabas: Current Practice and Guideline Adherence on Cancer-Associated Thrombosis in Turkey
Umut Kocabas, Cardiologist, Associate Professor at Başkent University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
”Excited to share our latest research article published in the Journal of Clinical Medicine: ‘Adherence of Oncologists and Cardiologists to Venous Thromboembolic Disease Prevention and Treatment Guidelines in Cancer Patients: A Cross-Sectional Survey from Turkey’
Our study investigated how closely oncologists and cardiologists in Turkey follow international guidelines for preventing and treating cancer-associated thrombosis (CAT).
Key Insights from our Findings:
- Where we succeed: There is strong alignment with international guidelines in perioperative and inpatient VTE prophylaxis, as well as acute treatment.
- Where we can improve: Significant implementation gaps persist in routine VTE risk stratification and primary prophylaxis for ambulatory cancer patients.
- A unified clinical approach: No significant differences were found between the practice patterns of oncologists and cardiologists, revealing a highly shared interdisciplinary baseline.
- The path forward: A striking 94.1% of clinicians expressed a clear desire to update their knowledge. This highlights an urgent need for structured multidisciplinary education, integration of validated risk scoring tools into clinical workflows, and nationally adapted guidelines.
I would like to express my sincere gratitude to Dr. Uğur Önsel Türk and the entire research team for their invaluable collaboration and dedication to this study!”
Title: Adherence of Oncologists and Cardiologists to Venous Thromboembolic Disease Prevention and Treatment Guidelines in Cancer Patients: A Cross-Sectional Survey from Turkey
Authors: Ugur Onsel Turk, Mehmet Emin Arayici, Umut Kocabas, Kivanc Yuksel, Yasemin Basbinar, Hulya Ellidokuz
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 11, 2026, 04:40Fernanda Orsi: Which Obstetric APS Patients Are More Likely to Develop Thromboses?
-
Jun 10, 2026, 18:22Winai Porntipworawech: The $50 Life-Saving Drug Big Pharma Doesn’t Want You to See
-
Jun 10, 2026, 18:09Leonard Valentino: Innovation in Blood Disorders Being Catalyzed by Pathway to Cures
-
Jun 10, 2026, 18:00Smitirupa Mishra: Normal Hemoglobin Does Not Always Mean Normal Genes
-
Jun 10, 2026, 17:58Talat Uppal: Addressing HMB with RACGP’s Dr. Ramya Raman
-
Jun 10, 2026, 17:52Throw Back Thursday to Past Bruises Posted in the Glanzmann’s Research Foundation
-
Jun 10, 2026, 17:52Priya Prasad: In Massive Hemorrhage, Fibrinogen Is Often the First Clotting Factor to Fall
-
Jun 10, 2026, 17:51Mariam Swidan: Some Red Blood Cells Can’t Handle Pressure
-
Jun 10, 2026, 17:49Ankit Mathur: Hosting ISBT Academy Day on Rare Donor Program in India